These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34076385)

  • 21. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
    Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
    Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
    Masarwy R; Shilo S; Carmel Neiderman NN; Kampel L; Horowitz G; Muhanna N; Mansour J
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review.
    Newman JG; Hall MA; Kurley SJ; Cook RW; Farberg AS; Geiger JL; Koyfman SA
    Head Neck; 2021 Sep; 43(9):2822-2843. PubMed ID: 34096664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Gene Expression Profiling on Decision-Making in Clinically Node Negative Melanoma Patients after Surgical Staging.
    Schuitevoerder D; Heath M; Cook RW; Covington KR; Fortino J; Leachman S; Vetto JT
    J Drugs Dermatol; 2018 Feb; 17(2):196-199. PubMed ID: 29462228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines.
    Peris K; Alaibac M; Argenziano G; Di Stefani A; Fargnoli MC; Frascione P; Gualdi G; Longo C; Moscarella E; Naldi L; Pellacani G; Pimpinelli N; Quaglino P; Salgarello M; Sollena P; Valentini V; Zalaudek I; Calzavara-Pinton PG;
    G Ital Dermatol Venereol; 2018 Dec; 153(6):747-762. PubMed ID: 29898593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the 40-gene Expression Profile (40-GEP) Test in Medicare-eligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs.
    Somani AK; Ibrahim SF; Tassavor M; Yoo J; Farberg AS
    J Clin Aesthet Dermatol; 2024 Jan; 17(1):41-44. PubMed ID: 38298751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry.
    Azimi A; Lo K; Kim J; Fernandez-Penas P
    J Dermatol Sci; 2020 Aug; 99(2):119-127. PubMed ID: 32651104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating the melanoma 31-gene expression profile test with surgical oncology practice within national guideline and staging recommendations.
    Hyams DM; Covington KR; Johnson CE; Plasseraud KM; Cook RW
    Future Oncol; 2021 Feb; 17(5):517-527. PubMed ID: 33021104
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
    Wysong A; Somani AK; Ibrahim SF; Cañueto J; Fitzgerald AL; Siegel JJ; Prasai A; Goldberg MS; Farberg AS; Regula C; Bar A; Kasprzak J; Brodland DG; Koyfman SA; Arron ST
    Dermatol Ther (Heidelb); 2024 Mar; 14(3):593-612. PubMed ID: 38424384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma.
    Willenbrink TJ; Jambusaria-Pahlajani A; Arron S; Seckin D; Harwood CA; Proby CM
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():57-60. PubMed ID: 31833603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
    Borman S; Wilkinson J; Meldi-Sholl L; Johnson C; Carter K; Covington KR; Fitzgerald AL; Kurley SJ; Farberg AS; Goldberg MS; Monzon FA; Oelschlager K; Cook RW
    Diagn Pathol; 2022 Feb; 17(1):32. PubMed ID: 35216597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Cutaneous Squamous Cell Carcinoma Is Associated with Suboptimal Initial Management in a Cohort of 109 Patients.
    Deilhes F; Boulinguez S; Pagès C; Paul C; Meyer N
    Dermatology; 2019; 235(6):516-521. PubMed ID: 31387094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
    Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
    J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis.
    Cañueto J; Tejera-Vaquerizo A; Redondo P; Botella-Estrada R; Puig S; Sanmartin O
    Actas Dermosifiliogr (Engl Ed); 2020 May; 111(4):281-290. PubMed ID: 32359704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk cutaneous squamous cell carcinoma.
    Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.